Clozapine in Patients with Chronic Schizophrenia: Serum Level, EEG and Memory Performance

G. Adler; S. Grieshaber; V. Faude; B. Thebaldi; H. Dressing

doi:10.1055/s-2002-34120

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000054.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Pharmacopsychiatry 2002; 35(5): 190-194
DOI: 10.1055/s-2002-34120

Original Paper

Clozapine in Patients with Chronic Schizophrenia: Serum Level, EEG and Memory Performance

G. Adler¹ , S. Grieshaber¹ , V. Faude¹ , B. Thebaldi¹ , H. Dressing²

¹Clinical Neurophysiology Service
²Psychiatric Day Clinic, Central Institute of Mental Health, Mannheim, Germany

Further Information

Publication History

Received: 26. 4. 2001 Revised: 5. 2. 2002

Accepted: 7. 3. 2002

Publication Date:
18 September 2002 (online)

Also available at

Abstract
Full Text
References

Buy Article Permissions and Reprints

The atypical antipsychotic clozapine causes EEG alterations, and may lead to memory impairments due to its anticholinergic properties. The relationships between clozapine serum level, quantitative EEG parameters and performance in vigilance and memory tasks were studied in a group of 17 chronically ill schizophrenic patients under maintenance treatment with clozapine at stable dosages. There were negative correlations between clozapine serum levels and the amount of high-frequency EEG activity and positive correlations between high-frequency EEG activity and memory performance. These findings may suggest that clozapine treatment brings about dose-dependent impairments of vigilance and memory, for which a reduction of high-frequency EEG activity is indicative.

References

1 Baldessarini R J, Centorrino F, Flood J G, Volpicelli S A, Huston-Lyons D, Cohen B M. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacol. 1993; 9 117-124

PubMed Search in Google Scholar
2 Conners C K. The continuous performance test. Toronto; Multi-Health Systems 1995

Search in Google Scholar
3 Coyle J T, Price D L, DeLong M R. Alzheimer’s disease: a disorder of central cholinergic innervation. Science. 1983; 219 1184-1190

PubMed Search in Google Scholar
4 Daniel D G, Goldberg T E, Weinberger D R, Kleinman J E, Pickar D, Lubick L J, Williams T S. Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study. Am J Psychiatry. 1996; 153 417-419

PubMed Search in Google Scholar
5 Drachman D A, Leavitt J. Human memory and the cholinergic system. Arch Neurol. 1974; 30 113-121

PubMed Search in Google Scholar
6 Folstein M F, Folstein S E, McHugh P R. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12 189-198

PubMed Search in Google Scholar
7 Freudenreich O, Weiner R D, McEvoy J P. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiat. 1997; 42 132-137

PubMed Search in Google Scholar
8 Gattaz W F, Mayer S, Ziegler P, Platz M, Gasser T. Hypofrontality on topographic EEG in schizophrenia: correlations with neuropsychological and psychopathological parameters. Eur Arch Psychiat Clin Neurosci. 1992; 241 328-332

PubMed Search in Google Scholar
9 Goldberg T E, Greenberg R D, Griffin S J, Gold J M, Kleinman J E, Pickar D, Schulz S C, Weinberger D R. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiat. 1993; 162 43-48

PubMed Search in Google Scholar
10 Goldberg T E, Weinberger D R. The effects of clozapine on neurocognition: an overview. J Clin Psychiatr. 1994; 55 (Suppl B) 88-90

PubMed Search in Google Scholar
11 Green M F. What are the functional consequences of neurocognitive deficits in schizophrenia. Am J Psychiatry. 1996; 153 321-330

PubMed Search in Google Scholar
12 Günther W, Baghai T, Naber D, Spatz R, Hippius H. EEG alterations and seizures during treatment with clozapine. Pharmacopsychiat. 1993; 26 69-74

PubMed Search in Google Scholar
13 Haring C, Neudorfer C, Schwitzer J, Hummer M, Saria A, Hinterhuber H, Fleischhacker W W. EEG alterations in patients treated with clozapine in relation to plasma levels. Psychopharmacology. 1994; 114 97-100

PubMed Search in Google Scholar
14 Helmstaedter C, Durwen H F. VLMT: Verbaler Lern- und Merkfähigkeitstest. Schweiz Arch Neurol Psychiat. 1990; 141 21-30

PubMed Search in Google Scholar
15 Ihl R, Dierks T, Martin E -M, Frölich L, Maurer K. Topography of the maximum of the amplitude of EEG frequency bands in dementia of the Alzheimer type. Biol Psychiat. 1996; 39 319-325

PubMed Search in Google Scholar
16 Katznelson R D. EEG recording, electrode placement and aspects of generator localization. In Nuñez PL (ed) Electrical fields of the brain. New York; Oxford University Press: 1981

Search in Google Scholar
17 Kay S R, Fiszbein A, Opler L A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13 261-276

PubMed Search in Google Scholar
18 Lee M A, Jayathilake K, Meltzer H Y. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophr Res. 1999; 37 1-11

PubMed Search in Google Scholar
19 Malow B A, Reese K B, Sato S, Bogard H J, Malhotra A K, Su T -P, Pickar D. Spectrum of EEG abnormalities during clozapine treatment. Electroenceph Clin Neurophysiol. 1994; 91 205-211

PubMed Search in Google Scholar
20 McGurk S R. The effects of clozapine on cognitive functioning in schizophrenia. J Clin Psychiatry. 1999; 60 (Suppl. 12) 24-29

PubMed Search in Google Scholar
21 Meltzer H Y, McGurk S R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull. 1999; 25 233-255

PubMed Search in Google Scholar
22 Metherate R, Cox C L, Ashe J H. Cellular bases of neocortical activation: modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine. J Neurosci. 1992; 12 4701-4711

PubMed Search in Google Scholar
23 Miller J L, Hiley C R. Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepine. Nauyn-Schmiedeberg’s Arch Pharmacol. 1976; 292 289-293

PubMed Search in Google Scholar
24 Nordström A L, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G. D1, D2 and 5-HT2-receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiat. 1995; 152 1444-1449

PubMed Search in Google Scholar
25 Rey A. L’examen de clinique en psychologie. Paris; Presses Universitaires de France 1964

Search in Google Scholar
26 Richelson E. Neuroleptics and neurotransmitter receptors. Psychiatr Ann. 1980; 10 21-26

PubMed Search in Google Scholar
27 Saletu B, Grunberger J, Linzmayer L, Anderer P. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry. Pharmacopsychiat. 1987; 20 12-27

PubMed Search in Google Scholar
28 Schuld A, Kühn M, Haack M, Kraus T, Hinze-Selch D, Lechner C, Pollmächter T. A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiat. 2000; 33 109-111

PubMed Search in Google Scholar
29 Semlitsch H V, Anderer P, Saletu B, Schuster P, Presslich O. A solution for reliable and valid reduction of ocular artefacts to the P300 ERP. Psychophysiology. 1986; 23 695-703

PubMed Search in Google Scholar
30 Taylor L B. Psychological assessment of neurosurgical patients. In Rasmussen T, Marino R (eds) Functional neurosurgery. New York; Raven Press 1979

Search in Google Scholar
31 Tracy J I, Monaco C A, Abraham G, Josiassen R C, Pollock B G. Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone. J Clin Psychiatry. 1998; 59 184-188

PubMed Search in Google Scholar
32 Wechsler D. Psychological Corporation. New York; 1981

Search in Google Scholar
33 Weigmann H, Hartter S, Fischer V, Dahmen N, Hiemke C. Distribution of clozapine and desmethylclozapine between blood and brain in rats. Eur Neuropsychopharmacol. 1999; 9 253-256

PubMed Search in Google Scholar
34 Welch J, Manschreck T, Redmond D. Clozapine-induced seizures and EEG changes. J Neuropsychiat Clin Neurosci. 1994; 6 250-256

PubMed Search in Google Scholar

Georg AdlerM.D.

Clinical Neurophysiology Service

Central Institute of Mental Health

P.O. Box 12 21 20

68072 Mannheim

Germany

Phone: +49 (621) 1703-792

Fax: +49 (621) 23 429

Email: adler@zi-mannheim.de